<DOC>
	<DOCNO>NCT00758732</DOCNO>
	<brief_summary>This trial compare efficacy docetaxel/carboplatin versus docetaxel/liposomal doxorubicin pretreated patient advanced ovarian carcinoma treatment free-interval least six month</brief_summary>
	<brief_title>Docetaxel/Carboplatin Versus Docetaxel/Caelyx Pretreated Patients With Ovarian Carcinoma</brief_title>
	<detailed_description>The second-line treatment advanced ovarian cancer prove effective prolong overall survival improve quality life . In patient platinum-sensitive ovarian cancer ( relapsed disease 6 month end first line chemotherapy ) combination paclitaxel/carboplatin consider standard treatment . Generally , combination platinum-based chemotherapy may well associate survival benefit patient platinum-sensitive disease . Carboplatin , pegylated doxorubicin ( caelyx ) docetaxel , approve second-line treatment ovarian carcinoma seem active platinum-sensitive disease .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Histologically confirm ovarian cancer Stage IIIB/IV Failure prior chemotherapy paclitaxel /carboplatin regimen treatment free interval &gt; 6 month Presence twodimensional measurable disease . Life expectancy 3 month . Age â‰¥ 18 year . Performance status ( WHO ) 02 Adequate bone marrow function ( Absolute neutrophil count &gt; 1000/mm^3 , Platelet count &gt; 100000/mm^3 , Hemoglobin &gt; 9gr/mm^3 ) Adequate liver ( Bilirubin &lt; 1.5 time upper limit normal SGOT/SGPT &lt; 2 time upper limit normal ) renal function ( creatinine &lt; 2mg/dl ) Informed consent Pregnant nursing Psychiatric illness social situation would preclude study compliance ' Other concurrent uncontrolled illness Other invasive malignancy within past 5 year except nonmelanoma skin cancer Other concurrent investigational agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Ovarian cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Pegylated doxorubicin</keyword>
	<keyword>Platinum sensitive</keyword>
</DOC>